SUBSCRIBE
SUBSCRIBE

Australia

High-Dose Vitamin D May Not Be Better Than Low-Dose Vitamin D in Treating Multiple Sclerosis, Royal Melbourne Hospital Study
October 25, 2011
 · 
1 min read
Obese Mothers Put Children At Higher Risk of Asthma, Murdoch Childrens Research Institute and University of Melbourne Study
October 11, 2011
 · 
1 min read
Is Female Hormone Disorder Tied to Familial Heart Risk? University of Adelaide Study
October 10, 2011
 · 
1 min read
Poor Footwear Linked to Foot Impairment and Disability in Gout Patients, Auckland University of Technology Study
October 3, 2011
 · 
1 min read
Early to Bed and Early to Rise: Study Suggests It’s Keeping Kids Leaner, University of South Australia Study
September 30, 2011
 · 
1 min read
New Genetic Region Responsible for Testicle Development Found, Children’s Hospital Melbourne Study
September 27, 2011
 · 
1 min read
Broccoli, Cabbage, Other Veggies May Protect Against Colon Cancer, Western Australian Institute for Medical Research Study
September 27, 2011
 · 
1 min read
Breakthrough Opens New Avenues for Hep C Vaccine, University of New South Wales Study
September 15, 2011
 · 
1 min read
Help For Stroke Patients Who Can’t Swallow, University of Adelaide Study
September 14, 2011
 · 
1 min read
New Approach to Treating Asthma in Pregnancy, The Lancet Reveals
September 12, 2011
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
February 18, 2026
 · 
9 min read
Press Releases
Klotho Neurosciences Receives Patent Claims in Australia for Composition and Use of Human Secreted Klotho Protein (“s-KL”) Isoform of the Human Klotho Gene Sequence
February 18, 2026
 · 
4 min read
Press Releases
Icon Group Deploys ChartCheck Adaptive Across Australia as Radformation Secures USFDA 510(k) Clearance
February 18, 2026
 · 
4 min read
Press Releases
Telix Submits European Marketing Authorization Application for TLX101-Px for Brain Cancer Imaging
February 18, 2026
 · 
10 min read
Press Releases
Australian Breast Cancer Innovators Close $27M Private Funding Round
February 12, 2026
 · 
5 min read
Press Releases
ImmuneSensor Therapeutics Doses First Patient with Aicardi Goutières Syndrome (AGS) in Phase 1b Clinical Study of cGAS inhibitor, IMSB301
February 12, 2026
 · 
5 min read
Press Releases
Amplia Therapeutics Announces Opening of US Sites for Amplicity Pancreatic Cancer Trial
February 11, 2026
 · 
4 min read
Press Releases
Genprex Announces IP Australia’s Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
February 10, 2026
 · 
8 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
 · 
4 min read
Press Releases
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
February 5, 2026
 · 
5 min read
Press Releases
Providence Therapeutics Announces Appointment of Leah Goodman to the Board of Directors
February 5, 2026
 · 
2 min read
Press Releases
Telix Full Year Results 2025 Investor Webcast Notification
February 4, 2026
 · 
5 min read
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
 · 
2 min read
Press Releases
Actinogen receives positive Interim Analysis recommendation from its independent Data Monitoring Committee to continue the XanaMIA pivotal Alzheimer’s disease trial
February 2, 2026
 · 
6 min read
Press Releases
AdvanCell Announces Collaboration and Exclusive Licensing Agreement with 48Hour Discovery to Develop a Novel Peptide-Based Lead-212 Radiotherapeutic for a Gastrointestinal Cancer with Significant Medical Need
February 2, 2026
 · 
3 min read
Press Releases
Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates
February 2, 2026
 · 
4 min read
Press Releases
Amplia Therapeutics - Quarterly Activities and Cash Flow Reports - December 2025
February 1, 2026
 · 
7 min read
Press Releases
Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)
February 1, 2026
 · 
11 min read
Press Releases
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
February 1, 2026
 · 
12 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
 · 
5 min read
Load More